Article Versions Notes

Brami I, Zuckerman T, Ram R, Avni B, Peretz G, Ostrovsky D, Lior Y, Faour C, McElvaney O, McElvaney NG, et al. Altered Serum Alpha1-Antitrypsin Protease Inhibition before and after Clinical Hematopoietic Stem Cell Transplantation: Association with Risk for Non-Relapse Mortality. International Journal of Molecular Sciences. 2024; 25(1):422. https://doi.org/10.3390/ijms25010422

Brami, Ido, Tsila Zuckerman, Ron Ram, Batia Avni, Galit Peretz, Daniel Ostrovsky, Yotam Lior, Caroline Faour, Oisin McElvaney, Noel G. McElvaney, and et al. 2024. "Altered Serum Alpha1-Antitrypsin Protease Inhibition before and after Clinical Hematopoietic Stem Cell Transplantation: Association with Risk for Non-Relapse Mortality" International Journal of Molecular Sciences 25, no. 1: 422. https://doi.org/10.3390/ijms25010422

Brami, I., Zuckerman, T., Ram, R., Avni, B., Peretz, G., Ostrovsky, D., Lior, Y., Faour, C., McElvaney, O., McElvaney, N. G., & Lewis, E. C. (2024). Altered Serum Alpha1-Antitrypsin Protease Inhibition before and after Clinical Hematopoietic Stem Cell Transplantation: Association with Risk for Non-Relapse Mortality. International Journal of Molecular Sciences, 25(1), 422. https://doi.org/10.3390/ijms25010422